Zamirowski Justin 4
4 · Better Therapeutics, Inc. · Filed May 18, 2022
Insider Transaction Report
Form 4
Zamirowski Justin
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-16$0.50/sh+35,236$17,618→ 35,236 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-16−35,236→ 45,303 totalExercise: $0.50Exp: 2030-08-13→ Common Stock (35,236 underlying)
Footnotes (1)
- [F1]The Assumed Option (as defined in the Agreement and Plan of Merger, dated April 6, 2021, as amended, by and among Mountain Crest Acquisition Corp. II, MCAD Merger Sub Inc. and Better Therapeutics, Inc.) vests as to 1/4th of the shares subject to the Assumed Option on July 27, 2021 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The Assumed Option was granted on August 14, 2020.